BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15861364)

  • 41. Rare case of post-varicella membranoproliferative glomerulonephritis presenting with massive proteinuria.
    Majumdar A; Atam V; Mishra M
    BMJ Case Rep; 2020 Mar; 13(3):. PubMed ID: 32169983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Making the diagnosis of Alport's syndrome.
    Pirson Y
    Kidney Int; 1999 Aug; 56(2):760-75. PubMed ID: 10432421
    [No Abstract]   [Full Text] [Related]  

  • 43. Pathology of the kidney in Alport's syndrome.
    Spear GS
    Pathol Annu; 1974; 9(0):93-138. PubMed ID: 4422868
    [No Abstract]   [Full Text] [Related]  

  • 44. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
    Heidet L; Gubler MC
    Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective? ].
    Morales E; Huerta A; Gutiérrez E; Gutiérrez Solís E; Segura J; Praga M
    Nefrologia; 2009; 29(5):421-9. PubMed ID: 19820754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Membranoproliferative hypocomplementemic glomerulonephritis.
    West CD
    Nephron; 1973; 11(2):134-46. PubMed ID: 4584081
    [No Abstract]   [Full Text] [Related]  

  • 47. Minimal change lesion with nephrotic syndrome and focal glomerular sclerosis. (Variations of minimal proliferative intercapillary glomerulonephritis with the nephrotic syndrome).
    Bohle A; Fischbach H; Wehner H; Woerz U; Edel HH; Kluthe R; Scheler F
    Clin Nephrol; 1974; 2(2):52-8. PubMed ID: 4830512
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.
    Freiberger V; Amann K; Heemann U; Frank H
    Transpl Int; 2009 Nov; 22(11):1110-3. PubMed ID: 19497068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The present status of focal glomerulonephritis.
    Heptinstall RH
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():287-300. PubMed ID: 4157259
    [No Abstract]   [Full Text] [Related]  

  • 51. Renin-Angiotensin-Aldosterone system inhibitors and statins prolong graft survival in post-transplant glomerulonephritis.
    Pazik J; Ostrowska J; Lewandowski Z; Mróz A; Perkowska-Ptasińska A; Baczkowska T; Durlik M
    Ann Transplant; 2008; 13(4):41-5. PubMed ID: 19034222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathologic characteristics of hereditary nephritis.
    Churg J; Sherman RL
    Arch Pathol; 1973 Jun; 95(6):374-9. PubMed ID: 4701392
    [No Abstract]   [Full Text] [Related]  

  • 53. Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis.
    Elliot V; Cairns T; Cook HT
    Am J Kidney Dis; 2006 Jan; 47(1):184-90. PubMed ID: 16377401
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
    Neverov NI; Stavrovskaia EV; Kolina IB; Shvetsov MIu; Zakharova EV; Shilov EM
    Ter Arkh; 2001; 73(6):37-40. PubMed ID: 11521519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doxycycline decreases proteinuria in glomerulonephritis.
    Ahuja TS
    Am J Kidney Dis; 2003 Aug; 42(2):376-80. PubMed ID: 12900822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis of Alport syndrome.
    Kashtan CE
    Kidney Int; 2004 Sep; 66(3):1290-1; author reply 1291. PubMed ID: 15327435
    [No Abstract]   [Full Text] [Related]  

  • 58. Hereditary nephritis mimicking immune complex-mediated glomerulonephritis.
    Nasr SH; Markowitz GS; Goldstein CS; Fildes RD; D'Agati VD
    Hum Pathol; 2006 May; 37(5):547-54. PubMed ID: 16647952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The nephrotic syndrome secondary to acute glomerulonephritis during falciparum malaria.
    Berger M; Birch LM; Conte NF
    Ann Intern Med; 1967 Dec; 67(6):1163-71. PubMed ID: 4863108
    [No Abstract]   [Full Text] [Related]  

  • 60. Differential diagnosis between X-linked Alport syndrome and thin basement membrane nephropathy.
    Rizzoni G; Massella L
    Kidney Int; 2004 Sep; 66(3):1289-90; author reply 1290. PubMed ID: 15327434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.